In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins

BMC Biotechnology

Jason S Buhrman¹  Jamie E Rayahin¹  Melanie Köllmer¹  Richard A Gemeinhart² 

[1] Department of Biopharmaceutical Sciences, University of Illinois, Chicago, IL, 60612-7231, USA

[2] Department of Ophthalmology and Visual Science, University of Illinois, Chicago, IL, 60612-4319, USA

关键词: Recombinant protein;    Batch purification;    Glutathione S-transferase;    PEGDA;    Glutathione;   

Others  :  1134851
DOI  :  10.1186/1472-6750-12-63

 received in 2012-06-06, accepted in 2012-09-17,  发布年份 2012

【 摘 要 】

Background

Many branches of biomedical research find use for pure recombinant proteins for direct application or to study other molecules and pathways. Glutathione affinity purification is commonly used to isolate and purify glutathione S-transferase (GST)-tagged fusion proteins from total cellular proteins in lysates. Although GST affinity materials are commercially available as glutathione immobilized on beaded agarose resins, few simple options for in-house production of those systems exist. Herein, we describe a novel method for the purification of GST-tagged recombinant proteins.

Results

Glutathione was conjugated to low molecular weight poly(ethylene glycol) diacrylate (PEGDA) via thiol-ene “click” chemistry. With our in-house prepared PEGDA:glutathione (PEGDA:GSH) homogenates, we were able to purify a glutathione S-transferase (GST) green fluorescent protein (GFP) fusion protein (GST-GFP) from the soluble fraction of E. coli lysate. Further, microspheres were formed from the PEGDA:GSH hydrogels and improved protein binding to a level comparable to purchased GSH-agarose beads.

Conclusions

GSH containing polymers might find use as in-house methods of protein purification. They exhibited similar ability to purify GST tagged proteins as purchased GSH agarose beads.

【 授权许可】

   
2012 Buhrman et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Jackson DA, Symons RH, Berg P: Biochemical method for inserting new genetic information into DNA of simian virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. 1972. Biotechnology 1992, 24:11-16.
• [2]King TP: Separation of proteins by ammonium sulfate gradient solubilization. Biochemistry 1972, 11(3):367-371.
• [3]Ghosh R, Cui ZF: Purification of lysozyme using ultrafiltration. Biotechnol Bioeng 2000, 68(2):191-203.
• [4]Cuatrecasas P: Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem 1970, 245(12):3059-3065.
• [5]Young CL, Britton ZT, Robinson AS: Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications. Biotechnol J 2012, 7(5):620-634.
• [6]Smith DB, Johnson KS: Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988, 67(1):31-40.
• [7]Inoue M, Hara M, Nagashima F, Matsui S, Mitsuyasu N, Morino Y: Affinity chromatography of hepatic glutathione S-transferases on omega-aminoalkyl sepharose derivatives of glutathione. Biochim Biophys Acta 1981, 659(2):362-369.
• [8]Spana C, Fargnoli J, Bolen JB: Expression system for Lck protein. BRISTOL-MYERS SQUIBB COMPANY, EU; 2000. EP 0 646 646 B1
• [9]Huang XB, Cyrille D, Thomas P, Bulmus V: Synthesis of Hetertelechelic polymers with affinity to glutathione-s-transferase and biotin-tagged proteins by RAFT polymerization and thiol-ene reactions. Polymer Chemistry 2011, 2:1505-1512.
• [10]Heim R, Cubitt AB, Tsien RY: Improved green fluorescence. Nature 1995, 373(6516):663-664.
• [11]Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF: The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003, 66(8):1499-1503.
• [12]Dirr H, Reinemer P, Huber R: X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function. Eur J Biochem 1994, 220(3):645-661.
• [13]Franco CL, Price J, West JL: Development and optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres. Acta Biomater 2011, 7(9):3267-3276.
• [14]Tauro JR, Lee BS, Lateef SS, Gemeinhart RA: Matrix metalloprotease selective peptide substrates cleavage within hydrogel matrices for cancer chemotherapy activation. Peptides 2008, 29(11):1965-1973.
• [15]Tauro JR, Gemeinhart RA: Extracellular protease activation of chemotherapeutics from hydrogel matrices: A new paradigm for local chemotherapy. Mol Pharm 2005, 2(5):435-438.
• [16]Tauro JR, Gemeinhart RA: Matrix metalloprotease triggered local delivery of cancer chemotherapeutics. Bioconjugate Chem 2005, 16(5):1133-1139.
• [17]Vartak DG, Gemeinhart RA: In vitro evaluation of functional interaction of integrin αvβ3 and matrix metalloprotease-2. Mol Pharm 2009, 6(6):1856-1867.
• [18]Ross AE, Tang MY, Gemeinhart RA: Effects of molecular weight and loading on matrix metalloproteinase-2 mediated release from poly(ethylene glycol) diacrylate hydrogels. AAPS J 2012, 14(3):482-490.
• [19]Zhang Y, Gemeinhart RA: Improving matrix metalloproteinase-2 specific response of a hydrogel system using electrophoresis. Int J Pharm 2012, 429(1–2):31-37.
• [20]Kopecek J: Smart and genetically engineered biomaterials and drug delivery systems. Eur J Pharm Sci 2003, 20(1):1-16.
• [21]Raps SP, Lai JC, Hertz L, Cooper AJ: Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 1989, 493(2):398-401.
• [22]Vartak D, Gemeinhart RA: Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target 2007, 15(1):1-21.
• [23]Overall CM, Kleifeld O: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006, 6(3):227-239.
• [24]Turk B: Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov 2006, 5(9):785-799.
• [25]Turk BE, Huang LL, Piro ET, Cantley LC: Determination of protease cleavage site motifs using mixture- based oriented peptide libraries. Nat Biotechnol 2001, 19(7):661-667.
• [26]Kratz F, Drevs J, Bing G, Stockmar C, Scheuermann K, Lazar P, Unger C: Development and in vitro efficacy of novel MMP2 and MMP9 specific doxorubicin albumin conjugates. Bioorg, Med Chem Let 2001, 11(15):2001-2006.
• [27]Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.